PREVECEUTICAL Trademark

Trademark Overview


On Friday, May 29, 2015, a trademark application was filed for PREVECEUTICAL with the United States Patent and Trademark Office. The USPTO has given the PREVECEUTICAL trademark a serial number of 86645468. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2017. This trademark is owned by Cornerstone Global Partners Inc.. The PREVECEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of Addison's Disease, Agammaglobulinemia, Alopecia Areata, Amyloidosis, Ankylosing Spondylitis, Anti-Gbm/Anti-Tbm Nephritis, Antiphospholipid Syndrome (Aps), Autoimmune Hepatitis, Autoimmune Inner Ear Disease (Aied), Axonal and Neuronal Neuropathy (Aman), Arthritis, Baló's Concentric Sclerosis (Bcs), Behcet's Disease, Bullous Pemphigoid, Cancer, Castleman Disease (Cd), Celiac Disease, Chagas Disease, Chronic Inflammatory Demyelinating Polyneuropathy (Cidp), Chronic Recurrent Multifocal Osteomyelitis (Crmo), Churg-Strauss, Cicatricial Pemphigoid/Benign Mucosal Pemphigoid, Cogan's Syndrome Cold Agglutinin Disease, Congenital Heart Block, Coxsackie Myocarditis, Crest Syndrome, Crohn's Disease, Dermatitis Herpetiformis, Dermatomyositis, Devic's Disease (Neuromyelitis Optica), Diabetes, Discoid Lupus, Dressler's Syndrome, Endometriosis, Essential Mixed Cryoglobulinemia, Eosinophilic Esophagitis (Eoe), Evans Syndrome, Fibromyalgia...
preveceutical

General Information


Serial Number86645468
Word MarkPREVECEUTICAL
Filing DateFriday, May 29, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of Addison's Disease, Agammaglobulinemia, Alopecia Areata, Amyloidosis, Ankylosing Spondylitis, Anti-Gbm/Anti-Tbm Nephritis, Antiphospholipid Syndrome (Aps), Autoimmune Hepatitis, Autoimmune Inner Ear Disease (Aied), Axonal and Neuronal Neuropathy (Aman), Arthritis, Baló's Concentric Sclerosis (Bcs), Behcet's Disease, Bullous Pemphigoid, Cancer, Castleman Disease (Cd), Celiac Disease, Chagas Disease, Chronic Inflammatory Demyelinating Polyneuropathy (Cidp), Chronic Recurrent Multifocal Osteomyelitis (Crmo), Churg-Strauss, Cicatricial Pemphigoid/Benign Mucosal Pemphigoid, Cogan's Syndrome Cold Agglutinin Disease, Congenital Heart Block, Coxsackie Myocarditis, Crest Syndrome, Crohn's Disease, Dermatitis Herpetiformis, Dermatomyositis, Devic's Disease (Neuromyelitis Optica), Diabetes, Discoid Lupus, Dressler's Syndrome, Endometriosis, Essential Mixed Cryoglobulinemia, Eosinophilic Esophagitis (Eoe), Evans Syndrome, Fibromyalgia, Fibrosing Alveolitis, Giant Cell Arteritis (Temporal Arteritis), Giant Cell Myocarditis, Glomerulonephritis, Goodpasture's Syndrome, Granulomatosis With Polyangiitis (Gpa), Graves' Disease, Guillain-Barre Syndrome, Hashimoto's Thyroiditis, Hemolytic Anemia, Henoch-Schonlein Purpura (Hsp), Herpes Gestationis Or Pemphigoid Gestationis (Pg), Hypogammalglobulinemia, Immune Thrombocytopenic Purpura (Itp), Iga Nephropathy, Inclusion Body Myositis (Ibm), Interstitial Cystitis (Ic), Juvenile Arthritis, Juvenile Diabetes (Type 1 Diabetes), Juvenile Myositis (Jm), Kawasaki Disease, Lambert-Eaton Syndrome, Leukocytoclastic Vasculitis, Lichen Planus, Lichen Sclerosus, Ligneous Conjunctivitis, Linear Iga Disease (Lad), Lupus, Lyme Disease, Meniere's Disease, Microscopic Polyangiitis (Mpa), Mixed Connective Tissue Disease (Mctd), Mooren's Ulcer, Mucha-Habermann Disease, Multiple Sclerosis (Ms), Myasthenia Gravis, Myositis, Narcolepsy, Neuromyelitis Optica, Neutropenia, Ocular Cicatricial Pemphigoid, Optic Neuritis, Palindromic Rheumatism (Pr), Pandas (Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcus), Paraneoplastic Cerebellar Degeneration (Pcd), Paroxysmal Nocturnal Hemoglobinuria (Pnh), Parry Romberg Syndrome, Parsonnage-Turner Syndrome, Pars Planitis, Pemphigus, Pernicious Anemia (Pa), Peripheral Neuropathy, Perivenous Encephalomyelitis, Poems Syndrome, Polyarteritis Nodosa, Polymyalgia Rheumatic, Polymyositis, Postmyocardial Infarction Syndrome, Postpericardiotomy Syndrome, Progesterone Dermatitis, Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, Psoriatic Arthritis, Idiopathic Pulmonary Fibrosis, Pyoderma Gangrenosum, Pure Red Cell Aplasia (Prca), Raynaud's Phenomenon, Reactive Arthritis, Reflex Sympathetic Dystrophy, Reiter's Syndrome, Relapsing Polychondritis, Restless Legs Syndrome (Rls), Retroperitoneal Fibrosis, Rheumatic Fever, Rheumatoid Arthritis (Ra), Sarcoidosis, Schmidt Syndrome, Scleritis, Scleroderma, Sjogren's Syndrome, Sperm and Testicular Autoimmunity, Stiff Person Syndrome (Sps), Subacute Bacterial Endocarditis (Sbe), Susac's Syndrome, Sympathetic Ophthalmia (So), Takayasu's Arteritis, Temporal Arteritis/Giant Cell Arteritis, Thrombocytopenic Purpura (Ttp), Tolosa-Hunt Syndrome (Ths), Transverse Myelitis, Type 1 Diabetes, Ulcerative Colitis (Uc), Undifferentiated Connective Tissue Disease (Uctd), Uveitis, Vasculitis, Vitiligo and Wegener's Granulomatosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePREVECEUTICAL MEDICAL INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10017

Party NameCornerstone Global Partners Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NameCornerstone Global Partners Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, February 27, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 27, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2016EXTENSION 1 GRANTED
Monday, July 25, 2016EXTENSION 1 FILED
Monday, July 25, 2016TEAS EXTENSION RECEIVED
Thursday, June 30, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 30, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 24, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 11, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 11, 2015NON-FINAL ACTION E-MAILED
Friday, September 11, 2015NON-FINAL ACTION WRITTEN
Thursday, September 10, 2015ASSIGNED TO EXAMINER
Wednesday, July 1, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, June 24, 2015ASSIGNED TO LIE
Tuesday, June 16, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 2, 2015NEW APPLICATION ENTERED IN TRAM